MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally
Top Cited Papers
Open Access
- 20 November 2024
- journal article
- research article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 24 (1) , 103693
Abstract
No abstract availableKeywords
This publication has 250 references indexed in Scilit:
- Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United KingdomJAMA Network Open, 2022
- Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating SyndromesJAMA Network Open, 2021
- Unilateral Leptomeningeal Enhancement in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G–Associated DiseaseJAMA Neurology, 2020
- Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating SyndromesJAMA Neurology, 2020
- Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody DiseaseJAMA Network Open, 2019
- Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein AutoantibodyJAMA Neurology, 2019
- Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated DisordersJAMA Neurology, 2018
- Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseJAMA Neurology, 2018
- Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG DiseaseJAMA Neurology, 2018
- Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein AntibodiesJAMA Neurology, 2014